vs
Cardinal Infrastructure Group Inc.（CDNL）与Orion Group Holdings Inc（ORN）财务数据对比。点击上方公司名可切换其他公司
奥里昂集团是源自芬兰的全球化制药企业，1917年成立，总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分，旗下全部生产基地与大部分研发部门均设立在芬兰。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
ORN
CD
CDNL| Q4 25 | — | $233.2M | ||
| Q3 25 | — | $225.1M | ||
| Q2 25 | — | $205.3M | ||
| Q1 25 | — | $188.7M | ||
| Q4 24 | — | $216.9M | ||
| Q3 24 | — | $226.7M | ||
| Q2 24 | — | $192.2M | ||
| Q1 24 | — | $160.7M |
净利润ORN
CD
CDNL| Q4 25 | — | $-240.0K | ||
| Q3 25 | — | $3.3M | ||
| Q2 25 | — | $841.0K | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $-6.6M | ||
| Q1 24 | — | $-6.1M |
毛利率ORN
CD
CDNL| Q4 25 | — | 11.6% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | — | 9.7% |
营业利润率ORN
CD
CDNL| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -1.9% |
净利率ORN
CD
CDNL| Q4 25 | — | -0.1% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | -0.7% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -3.8% |
每股收益（稀释后）ORN
CD
CDNL| Q4 25 | — | $-0.00 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $-0.19 |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
